Related Experiment Video
Updated: Aug 8, 2026

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Published on: November 27, 2014
MyD88-dependent signaling affects the development of meningococcal sepsis by nonlipooligosaccharide ligands
Laura Plant1, Hong Wan, Ann-Beth Jonsson
1Department of Medical Biochemistry and Microbiology, Biomedical Centrum, Uppsala University, 751 23 Uppsala, Sweden. Laura.Plant@smi.ki.se
Abstract:
The Toll-like receptors (TLRs) and the adaptor myeloid differentiation factor 88 (MyD88) are important in the innate immune defenses of the host to microbial infections. Meningococcal ligands signaling via TLRs control inflammatory responses, and stimulation can result in fulminant meningococcal sepsis. In this study, we show that the responses to nonlipooligosaccharide (non-LOS) ligands of meningococci are MyD88 dependent. An isogenic LOS-deficient mutant of the serogroup C meningococcal strain FAM20 caused fatal disease in wild type C57BL/6 mice that was not observed in MyD88-/- mice. Fatality correlated with high proinflammatory cytokine and C5a levels in serum, high neutrophil numbers in blood, and increased bacteremia at 24 h postinfection in the wild-type mice. Infection with the parent strain FAM20 resulted in fatality in 100% of the wild-type mice and 50% of the MyD88-/- mice. We conclude that both LOS and another neisserial ligand cause meningococcal sepsis in an in vivo mouse model and confirm that meningococcal LOS can act via both the MyD88- dependent and -independent pathways, while the non-LOS meningococcal ligand(s) acts only via the MyD88-dependent pathway.
Insights
Meningococcal sepsis is driven by lipooligosaccharide (LOS) and other ligands. Non-LOS ligands signal through the MyD88-dependent pathway, crucial for innate immunity against bacterial infections.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Toll-like receptors (TLRs) and myeloid differentiation factor 88 (MyD88) are key components of innate immunity against microbial infections.
- Meningococcal ligands, including lipooligosaccharide (LOS), activate TLRs, potentially leading to severe sepsis.
Purpose of the Study:
- To investigate the role of MyD88 in host defense against meningococcal infections.
- To differentiate the signaling pathways of LOS and non-LOS meningococcal ligands.
Main Methods:
- Utilized an isogenic LOS-deficient mutant of serogroup C Neisseria meningitidis (strain FAM20) in wild-type and MyD88-/- C57BL/6 mice.
- Monitored survival, serum cytokine and C5a levels, neutrophil counts, and bacteremia post-infection.
Main Results:
- LOS-deficient meningococci caused fatal disease in wild-type mice but not in MyD88-/- mice, indicating MyD88 dependence for non-LOS ligand effects.
- Fatality in wild-type mice correlated with elevated pro-inflammatory cytokines, C5a, neutrophils, and bacteremia.
- Wild-type mice infected with the parent strain had 100% fatality, while MyD88-/- mice had 50% fatality, suggesting both LOS and non-LOS ligands contribute to sepsis.
Conclusions:
- Both LOS and non-LOS meningococcal ligands contribute to sepsis in a mouse model.
- Non-LOS ligands exclusively signal through the MyD88-dependent pathway.
- Meningococcal LOS utilizes both MyD88-dependent and -independent pathways in sepsis pathogenesis.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
The JAK-STAT Signaling Pathway

